0

Neurturin human

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATIAR4248819
Descriptionrecombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
Assay≥98% (HPLC); ≥98% (SDS-PAGE)
Colorwhite to off-white
Formlyophilized
Impurity Content<0.1 EU/μg endotoxin, tested
Size20μG
Storage Conditions−20°C
1

CDNF Protein Therapy in Parkinson's Disease

Henri J Huttunen, Mart Saarma

Cell Transplant. 2019 Apr;28(4):349-366.

PMID: 30947516

1

Cryo-EM Analyses Reveal the Common Mechanism and Diversification in the Activation of RET by Different Ligands

Jie Li, Guijun Shang, Yu-Ju Chen, Chad A Brautigam, Jen Liou, Xuewu Zhang, Xiao-Chen Bai

Elife. 2019 Sep 19;8:e47650.

PMID: 31535977

1

Gene Therapy for Parkinson's Disease, An Update

Tobias M Axelsen, David P D Woldbye

J Parkinsons Dis. 2018;8(2):195-215.

PMID: 29710735

1

Role of Neurotrophic Factors in Parkinson's Disease

Diogo Tome, Carla Pais Fonseca, Filipa Lopes Campos, Graca Baltazar

Curr Pharm Des. 2017;23(5):809-838.

PMID: 27928963

1

Structure and Biophysical Characterization of the Human Full-Length neurturin-GFRa2 Complex: A Role for Heparan Sulfate in Signaling

Jenny Sandmark, Göran Dahl, Linda Öster, Bingze Xu, Patrik Johansson, Tomas Akerud, Anna Aagaard, Pia Davidsson, Janna M Bigalke, Maria Sörhede Winzell, G Jonah Rainey, Robert G Roth

J Biol Chem. 2018 Apr 13;293(15):5492-5508.

PMID: 29414779

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode